↓ Skip to main content

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

Overview of attention for article published in EBioMedicine, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 4,038)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
763 Dimensions

Readers on

mendeley
768 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Published in
EBioMedicine, January 2019
DOI 10.1016/j.ebiom.2018.12.052
Pubmed ID
Authors

Jamie N. Justice, Anoop M. Nambiar, Tamar Tchkonia, Nathan K. LeBrasseur, Rodolfo Pascual, Shahrukh K. Hashmi, Larissa Prata, Michal M. Masternak, Stephen B. Kritchevsky, Nicolas Musi, James L. Kirkland

X Demographics

X Demographics

The data shown below were collected from the profiles of 151 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 768 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 768 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 97 13%
Student > Bachelor 84 11%
Researcher 81 11%
Student > Master 75 10%
Other 46 6%
Other 111 14%
Unknown 274 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 173 23%
Medicine and Dentistry 87 11%
Agricultural and Biological Sciences 51 7%
Pharmacology, Toxicology and Pharmaceutical Science 28 4%
Nursing and Health Professions 22 3%
Other 104 14%
Unknown 303 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2128. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2024.
All research outputs
#4,156
of 25,564,614 outputs
Outputs from EBioMedicine
#8
of 4,038 outputs
Outputs of similar age
#58
of 444,994 outputs
Outputs of similar age from EBioMedicine
#2
of 128 outputs
Altmetric has tracked 25,564,614 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,038 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,994 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.